Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

The Go-to Stock if the Pandemic Persists


Unfortunately, the COVID-19 pandemic has persisted longer than everyone hoped it would, and the consequences of governmental reactions to it are still impacting the global economy. There are also the rise of coronavirus variants and the necessity of keeping isolation measures in place to consider, meaning that it's a good idea to start thinking about some "insurance plays" for your portfolio. One idea is life science tools and diagnostics company Danaher (NYSE: DHR). Here's how the stock can help a portfolio.

The pandemic artificially boosted demand for Danaher's diagnostic tests (which include coronavirus, flu, and respiratory viruses) and life science tools and equipment (also used to research coronavirus vaccines and therapies). As a result, the stock has had a great run (doubling since the start of 2020), and the fear is that once the pandemic subsides, investors will be left holding a highly rated stock just as it's about to witness a slowdown in sales.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
DHR
Share

Comments